For Canadian Residents Only
Multiple myeloma is a cancer of the plasma cells, which are found in your bone marrow.1
SARCLISA® can be used to treat patients with relapsed and refractory multiple myeloma and relapsed or refractory multiple myeloma.
Relapsed multiple myeloma means that the disease has come back after a given treatment has been used.2
Refractory multiple myeloma means that the disease did not respond to a given treatment or stopped responding to treatment.2
Talk to your healthcare professional to learn more about your medical condition.
To enter the site, please confirm you have read and agreed to the terms and conditions below.
Sanofi operates in Canada through affiliated companies including sanofi-aventis Canada Inc., Sanofi Pasteur Limited and Sanofi Consumer Health Inc. (collectively referred to as “Sanofi Canada”). Sanofi Canada maintains this Website (the “Website”) for your personal information, education and communication. Please feel free to browse the Website.
Through your access and use of the Website, you accept, without limitation or qualification, the terms and conditions (“Terms & Conditions”) set forth at https://www.sanofi.ca/en/terms-conditions and our Privacy Policy, found at https://www.sanofi.ca/en/privacy-policies, incorporated herein by reference. If you do not agree to these Terms & Conditions or the Privacy Policy, you must not access or use the Website.
Please read and accept the Terms of Use before entering the website.
